Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review.
about
c-Abl and Parkinson's Disease: Mechanisms and Therapeutic Potential.Changes of cerebrospinal fluid Aβ42, t-tau, and p-tau in Parkinson's disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis.Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?
P2860
Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Do CSF Biomarkers Predict Prog ...... patients? A Systematic Review.
@en
Do CSF Biomarkers Predict Prog ...... patients? A Systematic Review.
@nl
type
label
Do CSF Biomarkers Predict Prog ...... patients? A Systematic Review.
@en
Do CSF Biomarkers Predict Prog ...... patients? A Systematic Review.
@nl
prefLabel
Do CSF Biomarkers Predict Prog ...... patients? A Systematic Review.
@en
Do CSF Biomarkers Predict Prog ...... patients? A Systematic Review.
@nl
P2860
P1476
Do CSF Biomarkers Predict Prog ...... patients? A Systematic Review.
@en
P2093
Katherine Leaver
Kathleen L Poston
P2860
P2888
P304
P356
10.1007/S11065-015-9307-8
P577
2015-12-01T00:00:00Z